But the legislation, the Treat and Reduce Obesity Act, has not made progress despite being reintroduced every year since 2012, and sponsors are now asking federal officials instead to rewrite existing rules
RYBELSUS and OZEMPIC tablets are not approved for subcutaneous use
Understanding how deep to inject semaglutide ensures optimal medication absorption, therapeutic effectiveness, and minimal side effects
About 1 in 8 people in the United States now take a glucagon-like peptide-1, or GLP-1, medication for weight loss, diabetes, or another condition, according to a KFF poll
Choosing the right diluent for semaglutide Not all water is the same